"Neoplasm Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
Descriptor ID |
D009363
|
MeSH Number(s) |
D12.776.624
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Proteins".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Proteins".
This graph shows the total number of publications written about "Neoplasm Proteins" by people in this website by year, and whether "Neoplasm Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 15 | 7 | 22 |
1995 | 27 | 10 | 37 |
1996 | 40 | 16 | 56 |
1997 | 28 | 16 | 44 |
1998 | 46 | 15 | 61 |
1999 | 42 | 19 | 61 |
2000 | 31 | 29 | 60 |
2001 | 28 | 22 | 50 |
2002 | 34 | 25 | 59 |
2003 | 50 | 39 | 89 |
2004 | 37 | 33 | 70 |
2005 | 40 | 38 | 78 |
2006 | 42 | 18 | 60 |
2007 | 47 | 36 | 83 |
2008 | 20 | 33 | 53 |
2009 | 38 | 26 | 64 |
2010 | 40 | 29 | 69 |
2011 | 47 | 20 | 67 |
2012 | 35 | 32 | 67 |
2013 | 47 | 15 | 62 |
2014 | 42 | 25 | 67 |
2015 | 59 | 16 | 75 |
2016 | 33 | 20 | 53 |
2017 | 33 | 19 | 52 |
2018 | 49 | 17 | 66 |
2019 | 30 | 16 | 46 |
2020 | 36 | 13 | 49 |
2021 | 32 | 15 | 47 |
2022 | 3 | 4 | 7 |
2023 | 0 | 4 | 4 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Proteins" by people in Profiles.
-
A GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis. Nat Commun. 2024 Mar 02; 15(1):1947.
-
Monoallelic variation in DHX9, the gene encoding the DExH-box helicase DHX9, underlies neurodevelopment disorders and Charcot-Marie-Tooth disease. Am J Hum Genet. 2023 08 03; 110(8):1394-1413.
-
Sarcoma with MGA::NUTM1 fusion: a report of three cases and literature review. Histopathology. 2023 Nov; 83(5):712-721.
-
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial. Nat Med. 2023 01; 29(1):104-114.
-
Detection of Gasdermin C-Mediated Cancer Cell Pyroptosis. Methods Mol Biol. 2023; 2641:135-146.
-
The Effect of Tobacco Use on the Expression of Placental Transporters in Alaska Native Women. Clin Pharmacol Ther. 2023 03; 113(3):634-642.
-
Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis. Cell Mol Immunol. 2022 10; 19(10):1153-1167.
-
Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain Tumors. J Pharmacol Exp Ther. 2022 10; 383(1):91-102.
-
Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy. Proc Natl Acad Sci U S A. 2022 03 22; 119(12):e2100670119.
-
A rare case of acute megakaryoblastic leukemia with t(11;17)(q23;q21) and KMT2A::MLLT6 fusion. Ann Hematol. 2022 07; 101(7):1579-1581.